Reported 2026-09-17Lot GRCG15-092026-199.99% purity · Cagrilintide - 2.55 mg, GLP RT - 13.18 mg
Open COA
Lyophilized Peptides
Retatrutide / Cagrilintide Research Blend
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatalogGRCG-PW
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
Price range: $135.00 through $210.00 — or from Original price was: $135.00.$114.75Current price is: $114.75. / month Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
Subscribe monthly and save 15%$114.75 per delivery. The same price applies to the first order and recurring renewals.
- Guest checkout
- All major cards
- COA per lot
- 2-day shipping
- Cancel anytime
Retatrutide / Cagrilintide Research Blend$135.00COA available
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
13 approved certificates are attached to this product record.
Reported 2026-07-02Lot GRCG30-042026-199.90% purity
Open COA
Reported 2026-06-15Lot GRCG30-062026-499.82% purity · Cagrilintide - 5.20 mg, GLP RT - 28.25 mg
Open COA
View all historical COAs (10)
Reported 2026-06-15Lot GRCG30-062026-499.82% purity · Cagrilintide - 5.20 mg, GLP RT - 28.25 mg
Open COA
Reported 2026-04-07Lot GRCG15-042026-199.938% purity
Open COA
Reported 2026-03-12Lot GBCG-032026-499.94% purity · Cagrilintide – 2.68 mg GLP RT – 18.19 mg
Open COA
Reported 2026-03-12Lot GBCG-032026-499.94% purity · Cagrilintide - 2.68 mg GLP RT - 18.19 mg
Open COA
Reported 2026-02-25Lot GRCG1025-0226-J99.92% purity · Cagrilintide – 2.95 mg GLP RT – 16.64 mg
Open COA
Reported 2026-02-25Lot GRCG1025-0226-J99.92% purity · Cagrilintide – 2.95 mg GLP RT – 16.64 mg
Open COA
Reported 2026-02-17Lot GRCG-06080-P99.553% purity
Open COA
Reported 2025-11-23Lot GPC0111592025-J99.92% purity · 12.5mg/2.5mg
Open COA
Reported 2025-08-30Lot RETCAG08272025-0299.87% purity · Caglirrintide: 3.01 mg, Retratrutide: 15.05 mg
Open COA
Reported 2025-08-30Lot RETCAG08272025-0299.87% purity · Cagrilitide: 3.01 mg, Retratrutide: 15.05 mg
Open COA
Technical information
Record at a glance
- Primary catalog
- Lyophilized Peptides
- Product type
- Variable product
- Availability
- Available
- Lot control
- Current lot documentation and approved product record control
- Catalog number
- GRCG-PW
Intended laboratory context
Illustrative applications
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Documentation package
Documentation
- PDFCertificate of Analysis / lot recordSample
- PDFProduct data or handling recordSample
- PDFSupporting product media archiveSample
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
Need a current record?
Documentation before decision-making.
Reference GRCG-PW and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model
